US28622K1043 - Common Stock
Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications...
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc. Announces Encouraging Research Data Results Indicating Potential for Hair Restoration Using Proprietary ...
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™...
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai EnfinityTM...
Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data...
Elevai Labs just reported results for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Elevai Labs (NASDAQ:ELAB) just reported results for the second quarter of 2024....
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update...
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD...
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line ...
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024...
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs ...
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Elevai Labs (NASDAQ:ELAB) just reported results for the first quarter of 2024.E...
Elevai Labs just reported results for the first quarter of 2024.
Elevai Labs Inc. Reports First Quarter 2024 Financial Results ...
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity...
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare...